Effects of Interfascial Injection of 10% Dextrose and 1% Lidocaine under Ultrasonography for Myofascial Pain Syndrome: A Randomized Controlled and Double-Blind Clinical Trial

Phase 2

• Conditions: Participants with myofascial pain syndrome in upper trapezius muscles; Myofascial pain syndrome

• Registration Number: TCTR20210202001
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-02
• Study Completion: 2021-12-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Age >/= 18 years old
2. Have symptoms and signs consistant with myofascial pain syndrome of upper trapezius muscles and these symptoms persist more than 3 months
3. Self reported pain score >/= 4 from numeric rating scale (NRS) 0-10

Exclusion Criteria

1.Has been diagnosed with cervical radiculopathy or history of cerival myelopathy
2.Previos history of surgery related to cervical and neck region within 1 year
3.Previos history of steroid and/or local anesthetic agent injection in the affected neck or shoulder side within 1 year
4.Have signs and symptoms of fibromyalgia
5.History of allergy to lidocaine or dextrose solution
6.Has one of these contraindication for injection such as skin infection in injected region, coagulapathy problem etc.
7.Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms pain intensity Before procedure; Immediately post-procedure, at 72 hr and 2 weeks post-procedure NRS

Secondary Outcome Measures

Name	Time	Method
Pain intensity during injection immediately post-procedure NRS,Cervical Range of Motion before procedure; immediately and at 2 weeks post-procedure degree of motion,Neck functional score before procedure and at 2 week after procedure Neck Disability Index